DNA Worldwide

Executive Summary

DNA Worldwide, founded in 2004 and headquartered in London, is a private provider of direct-to-consumer and legal DNA testing services. The company specializes in paternity, family relationship, ancestry, and immigration testing, leveraging high-density genetic analysis and ISO 17025 accreditation to position itself as offering the world's most accurate DNA tests. Its services cater to both personal peace of mind and legal/immigration evidentiary requirements, serving customers in the UK and internationally. As a mature player in the genetics and genomics space, DNA Worldwide benefits from a strong reputation in the legal and immigration testing niche, which provides a steady revenue stream due to regulatory requirements. However, the company faces competition from larger players like 23andMe and AncestryDNA, and its private status limits visibility into financial performance and growth strategy. The company's growth potential hinges on expanding its service offerings and geographic reach. Key opportunities include broadening into health-related genetic testing and leveraging partnerships with immigration authorities or law firms. Risks include regulatory changes that could reduce demand for immigration DNA tests and increasing commoditization of ancestry testing. Overall, DNA Worldwide is a stable but low-growth business with a niche focus. Its conviction score reflects a moderate outlook, given the lack of recent funding rounds or public catalysts.

Upcoming Catalysts (preview)

• Q4 2026Expansion of UK Immigration DNA Testing Requirements60% success
• Q2 2026Launch of New Genetic Health Risk Tests40% success
• TBDPartnership with a Major Ancestry Platform30% success